Boundless Bio, Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.93% | 7.66% | -2.13% | -35.44% | -25.32% |
| Total Depreciation and Amortization | 18.32% | 19.62% | 20.53% | 19.84% | 11.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.03% | 71.19% | 88.71% | 338.62% | 564.88% |
| Change in Net Operating Assets | 14.15% | 391.48% | 41.44% | -525.56% | 197.43% |
| Cash from Operations | 23.15% | 27.14% | 7.90% | -33.18% | -8.84% |
| Capital Expenditure | 96.89% | 96.81% | 28.92% | -73.88% | -219.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.60% | 117.00% | -82.88% | -85.76% | 398.88% |
| Cash from Investing | -52.65% | 116.56% | -83.13% | -88.47% | 386.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.87% | -- | 189.74% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 97.56% |
| Cash from Financing | 100.00% | -99.87% | -- | 108.16% | 97.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.80% | -106.75% | -898.19% | -596.97% | 143.49% |